Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]β-CIT SPECT study: preliminary report

Tablets sold as ecstasy often contain not only 3,4-methylenedioxymethamphetamine (MDMA) but other compounds well known to cause dopaminergic neurotoxicity, such as (meth)amphetamine. Furthermore, the use of ecstasy in the Netherlands is often combined with the use of amphetamine. However, little is...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Psychopharmacologia 2002, Vol.159 (3), p.335-340
Hauptverfasser:	RENEMAN, Liesbeth, BOOIJ, Jan, LAVALAYE, Jules, DE BRUIN, Kora, REITSMA, Johannes B, GUNNING, W. Boudewijn, DEN HEETEN, Gerard J, VAN DEN BRINK, Wim
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adrenergic Uptake Inhibitors - metabolism Adult Amphetamine - metabolism Amphetamines Analysis of Variance Biological and medical sciences Cocaine - analogs & derivatives Cocaine - metabolism Confidence Intervals Corpus Striatum - metabolism Dopamine Dopamine Plasma Membrane Transport Proteins Dopamine receptors Dopamine transporter Dopamine Uptake Inhibitors - metabolism Drug abuse Drug addictions Ecstasy Female Humans Iodine Radioisotopes - metabolism Male MDMA Medical sciences Membrane Glycoproteins Membrane Transport Proteins - metabolism Middle Aged N-Methyl-3,4-methylenedioxyamphetamine - metabolism Neostriatum Nerve Tissue Proteins Neurotoxicity Radiopharmaceuticals - metabolism Tomography, Emission-Computed, Single-Photon - methods Tomography, Emission-Computed, Single-Photon - statistics & numerical data Toxicology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!